Ultragenyx Pharmaceutical Inc. Quarterly Return On Assets in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Ultragenyx Pharmaceutical Inc. quarterly/annual Return On Assets history and growth rate from Q3 2014 to Q3 2024.
  • Ultragenyx Pharmaceutical Inc. Return On Assets for the quarter ending September 30, 2024 was -37.6 %, a 19.1% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Return On Assets for 2023 was -44.7 %, a 7.22% increase from 2022.
  • Ultragenyx Pharmaceutical Inc. annual Return On Assets for 2022 was -48.2 %, a 62.4% decline from 2021.
  • Ultragenyx Pharmaceutical Inc. annual Return On Assets for 2021 was -29.7 %, a 122% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -37.6 +8.84 +19.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -41.4 +7.82 +15.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -45.9 +3.14 +6.41% Jan 1, 2024 Mar 31, 2024
Q4 2023 -44.7 +3.48 +7.22% Oct 1, 2023 Dec 31, 2023
Q3 2023 -46.4 +0.01 +0.02% Jul 1, 2023 Sep 30, 2023
Q2 2023 -49.2 -13.8 -38.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -49 -17.2 -53.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -48.2 -18.5 -62.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -46.4 -24 -107% Jul 1, 2022 Sep 30, 2022
Q2 2022 -35.4 -12.5 -54.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -31.9 -18.1 -132% Jan 1, 2022 Mar 31, 2022
Q4 2021 -29.7 -16.3 -122% Oct 1, 2021 Dec 31, 2021
Q3 2021 -22.4 -1.67 -8.06% Jul 1, 2021 Sep 30, 2021
Q2 2021 -22.9 +3.44 +13.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -13.7 +26.7 +66.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -13.4 +27.1 +66.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -20.7 +23.8 +53.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -26.4 +16.7 +38.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -40.4 -1.04 -2.64% Jan 1, 2020 Mar 31, 2020
Q4 2019 -40.5 -15 -59.1% Oct 1, 2019 Dec 31, 2019
Q3 2019 -44.5 -17.9 -67.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -43 -14.2 -49.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -39.4 -3.02 -8.31% Jan 1, 2019 Mar 31, 2019
Q4 2018 -25.4 +35.9 +58.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -26.6 +31.2 +54% Jul 1, 2018 Sep 30, 2018
Q2 2018 -28.8 +24.1 +45.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -36.4 +13.8 +27.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -61.4 -13.7 -28.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -57.8 -13.6 -30.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -52.9 -15.2 -40.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 -50.2 -15.3 -43.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -47.7 -16.4 -52.4% Oct 1, 2016 Dec 31, 2016
Q3 2016 -44.2 -15.6 -54.5% Jul 1, 2016 Sep 30, 2016
Q2 2016 -37.7 -7.42 -24.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -34.9 -5.76 -19.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -31.3 +0.84 +2.61% Oct 1, 2015 Dec 31, 2015
Q3 2015 -28.6 +7.31 +20.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 -30.2 Apr 1, 2015 Jun 30, 2015
Q1 2015 -29.1 Jan 1, 2015 Mar 31, 2015
Q4 2014 -32.1 Oct 1, 2014 Dec 31, 2014
Q3 2014 -35.9 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.